Anika Therapeutics, Inc. (ANIK) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.34 -2.02%
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q3 EPS of $0.40, $0.07 better than the analyst estimate of $0.33. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $20.33 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Nebius Group closes $5.75B convertible notes offering
- Pinduoduo (PDD) Tops Q2 EPS by 98c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
